Oxford Covid vaccine will be ready by year-end if Phase 3 trials go well: Adar Poonawalla
- 4 years ago
A day after the Lancet published the first human trial data of the Covid-19 vaccine being developed by the Oxford University, Serum Institute of India CEO Adar Poonawalla said the vaccine will be ready by yearend if Phase 3 trials go well.